Combining Innovation and Industrial Strength to Advance the Future of Biopharmaceutical Manufacturing

On January 16, Hzymes Biotechnology Co., Ltd. (Hzymes) and Angel Yeast Co., Ltd (Angel Yeast) officially signed a strategic cooperation agreement, marking a significant milestone in the advancement of recombinant protein industrialization and synthetic biology innovation.

The signing ceremony was attended by Zuo Xiao, Secretary of the Xiaoting District Committee; Ruan Weihong, Director of the Shanghai Office of the Yichang Municipal Government; Xiong Tao, Party Secretary and Chairman of Angel Yeast; Yang Guangyu, Chairman of Hzymes; and Chen Xilin, Vice General Manager of Hzymes.

Under this strategic partnership, the two companies will leverage their complementary strengths to jointly develop and commercialize high-end recombinant proteins, while expanding cooperation in peptide drug intermediates, novel food proteins, and advanced enzyme products. The collaboration aims to bridge the gap between biotechnology innovation and large-scale manufacturing, accelerating the transition of scientific breakthroughs into real-world applications.

Xu Weiying, Member of the Standing Committee of the Yichang Municipal Committee and Executive Vice Mayor of Yichang, stated:

“This strategic partnership provides an opportunity to establish a long-term and stable collaboration mechanism, promoting the broader application of high-end recombinant protein technologies and supporting the growth of the biomanufacturing industry.”

The partnership also strengthens Yichang’s synthetic biology ecosystem and enhances the city's position in high-value biomanufacturing and biotechnology innovation.

Addressing One of Biotech’s Biggest Challenges: From R&D to Industrialization

The global biopharmaceutical and synthetic biology sectors are entering a period of rapid growth. However, many innovative technologies still face significant barriers on the path to commercialization.

Scaling from Laboratory Research to Industrial Production

One of the most common challenges in biotechnology is translating successful laboratory-scale research into reliable, cost-effective, and large-scale manufacturing processes. The transition from milligram-scale development to ton-scale production often requires extensive expertise in process optimization, quality control, and industrial fermentation.

Accelerating Commercialization in a Competitive Market

For biotechnology startups and innovation-driven companies, bringing products to market efficiently remains a critical challenge. Optimizing resource allocation, reducing development risks, and shortening commercialization timelines are essential for long-term success.

As demand grows for recombinant proteins, enzymes, biopharmaceutical raw materials, and synthetic biology solutions, the industry increasingly requires stronger collaboration between technology innovators and large-scale manufacturing partners.

The strategic alliance between Hzymes and Angel Yeast was established with this objective in mind—combining scientific innovation with industrial capabilities to accelerate product development and commercialization.

Leveraging Complementary Expertise Across the Biomanufacturing Value Chain

Hzymes and Angel Yeast have built a strong foundation of trust through years of cooperation within the biotechnology industry. This new partnership expands that relationship and creates a more integrated innovation-to-manufacturing ecosystem.

Hzymes: Driving Innovation in Recombinant Proteins and Synthetic Biology

As a National High-Tech Enterprise and Specialized and Sophisticated “Little Giant” Enterprise, Hzymes has developed extensive expertise in:

• Recombinant proteins
• Synthetic biology
• Specialty enzymes
• Molecular diagnostics raw materials
• Biopharmaceutical process solutions

With a technology-driven approach and a comprehensive R&D platform, Hzymes continues to advance innovative products that support global healthcare, life science research, and biomanufacturing applications.

Angel Yeast: Enabling Large-Scale Biomanufacturing Excellence

Angel Yeast brings decades of experience in industrial biotechnology and fermentation manufacturing, supported by:

• World-class large-scale production facilities
• International quality and compliance systems
• Advanced fermentation and downstream processing capabilities
• Global sales and distribution networks
• Strong supply chain integration resources

By combining Hzymes’ innovation capabilities with Angel Yeast’s industrial manufacturing expertise, the partnership creates a powerful platform for accelerating the development and commercialization of high-value biotechnology products.

Advancing Recombinant Protein Manufacturing and Synthetic Biology Applications

Driven by the rapid expansion of the global biomanufacturing market, Hzymes and Angel Yeast will focus on creating scalable solutions that support the growing demand for:

• High-end recombinant proteins
• Peptide drug intermediates
• Novel food proteins
• Specialty enzymes
• Synthetic biology products
• Biopharmaceutical manufacturing applications

The collaboration will cover the entire value chain, from product research and development to process optimization, scale-up production, commercialization, and market expansion.

This integrated approach is designed to shorten development cycles, improve manufacturing efficiency, and accelerate the delivery of innovative biotechnology products to customers worldwide.

Building an Open and Collaborative Future for Biomanufacturing

The partnership between Hzymes and Angel Yeast reflects a shared commitment to advancing biotechnology innovation through collaboration.

Rather than a traditional business relationship, this alliance is built on complementary expertise, shared resources, and a common vision for the future of biomanufacturing.

As the biotechnology industry continues to evolve, Hzymes remains committed to supporting innovation in recombinant proteins, synthetic biology, specialty enzymes, and biopharmaceutical raw materials.

We look forward to working with industry partners, researchers, and innovators worldwide to accelerate technology commercialization, solve industry challenges, and contribute to the next generation of biomanufacturing solutions.

Together, Hzymes and Angel Yeast are helping transform scientific innovation into scalable industrial impact.